TY - JOUR
T1 - Growth hormone therapy before and after pediatric renal transplant
AU - Acott, Philip D.
AU - Pernica, Jeffrey M.
PY - 2003/12
Y1 - 2003/12
N2 - Children undergoing successful renal transplantation anticipate optimal growth and development. The use of rhGH pre- and post-Tx has been evaluated and supported by randomized control trials. Several strategies are required to maximize the potential benefit of this treatment in the renal population including provision of adequate nutrition intake, following bone parameters with appropriate interventions, and strategies to reduce steroid therapy including utilization of alternate day steroid treatment. Studies are required to further assess the impact of rhGH on renal allograft function, rejection risk, and allograft ultrastructural changes.
AB - Children undergoing successful renal transplantation anticipate optimal growth and development. The use of rhGH pre- and post-Tx has been evaluated and supported by randomized control trials. Several strategies are required to maximize the potential benefit of this treatment in the renal population including provision of adequate nutrition intake, following bone parameters with appropriate interventions, and strategies to reduce steroid therapy including utilization of alternate day steroid treatment. Studies are required to further assess the impact of rhGH on renal allograft function, rejection risk, and allograft ultrastructural changes.
UR - http://www.scopus.com/inward/record.url?scp=0344413636&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0344413636&partnerID=8YFLogxK
U2 - 10.1046/j.1397-3142.2003.00108.x
DO - 10.1046/j.1397-3142.2003.00108.x
M3 - Review article
C2 - 14870889
AN - SCOPUS:0344413636
SN - 1397-3142
VL - 7
SP - 426
EP - 440
JO - Pediatric Transplantation
JF - Pediatric Transplantation
IS - 6
ER -